Next Article in Journal
Stroke Prevention in Atrial Fibrillation: Latest Clinical Trials and Guidelines
Next Article in Special Issue
A Perspective on the Comparative Antileukemic Activity of 5-Aza-2′-deoxycytidine (Decitabine) and 5-Azacytidine (Vidaza)
Previous Article in Journal
On the Regulatory Approval Pathway of Biosimilar Products
Previous Article in Special Issue
DNA Methylation as Clinically Useful Biomarkers—Light at the End of the Tunnel
Pharmaceuticals 2012, 5(4), 369-383; doi:10.3390/ph5040369

Notes on Article Versions

article html file updated23 January 2013 14:25 CET
article html file updated26 January 2013 09:26 CET
article html file updated29 January 2013 02:38 CET
article html file updated6 February 2013 06:58 CET
article html file updated7 February 2013 01:33 CET
article html file updated7 February 2013 11:33 CET
article xml file uploaded6 August 2013 16:03 CEST
article html file updated6 August 2013 16:03 CEST
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert